Cargando…

UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis

OBJECTIVES: (1) To explore existing knowledge of, and attitudes, to group B meningococcal disease and serogroup B meningococcal (MenB) vaccine among parents of young children. (2) To seek views on their information needs. DESIGN: Cross-sectional qualitative study using individual and group interview...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Cath, Yarwood, Joanne, Saliba, Vanessa, Bedford, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Open 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623433/
https://www.ncbi.nlm.nih.gov/pubmed/28473508
http://dx.doi.org/10.1136/bmjopen-2016-012851
_version_ 1783268085444116480
author Jackson, Cath
Yarwood, Joanne
Saliba, Vanessa
Bedford, Helen
author_facet Jackson, Cath
Yarwood, Joanne
Saliba, Vanessa
Bedford, Helen
author_sort Jackson, Cath
collection PubMed
description OBJECTIVES: (1) To explore existing knowledge of, and attitudes, to group B meningococcal disease and serogroup B meningococcal (MenB) vaccine among parents of young children. (2) To seek views on their information needs. DESIGN: Cross-sectional qualitative study using individual and group interviews conducted in February and March 2015, prior to the introduction of MenB vaccine (Bexsero) into the UK childhood immunisation schedule. SETTING: Community centres, mother and toddler groups, parents’ homes and workplaces in London and Yorkshire. PARTICIPANTS: 60 parents of children under 2 years of age recruited via mother and baby groups and via an advert posted to a midwife-led Facebook group. RESULTS: Although recognising the severity of meningitis and septicaemia, parents’ knowledge of group B meningococcal disease and MenB vaccine was poor. While nervous about fever, most said they would take their child for MenB vaccination despite its link to fever. Most parents had liquid paracetamol at home. Many were willing to administer it after MenB vaccination as a preventive measure, although some had concerns. There were mixed views on the acceptability of four vaccinations at the 12-month booster visit; some preferred one visit, while others favoured spreading the vaccines over two visits. Parents were clear on the information they required before attending the immunisation appointment. CONCLUSIONS: The successful implementation of the MenB vaccination programme depends on its acceptance by parents. In view of parents’ recognition of the severity of meningitis and septicaemia, and successful introduction of other vaccines to prevent bacterial meningitis and septicaemia, the MenB vaccination programme is likely to be successful. However, the need for additional injections, the likelihood of post-immunisation fever and its management are issues about which parents will need information and reassurance from healthcare professionals. Public Health England has developed written information for parents, informed by these findings.
format Online
Article
Text
id pubmed-5623433
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Open
record_format MEDLINE/PubMed
spelling pubmed-56234332017-10-10 UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis Jackson, Cath Yarwood, Joanne Saliba, Vanessa Bedford, Helen BMJ Open Immunology (Including Allergy) OBJECTIVES: (1) To explore existing knowledge of, and attitudes, to group B meningococcal disease and serogroup B meningococcal (MenB) vaccine among parents of young children. (2) To seek views on their information needs. DESIGN: Cross-sectional qualitative study using individual and group interviews conducted in February and March 2015, prior to the introduction of MenB vaccine (Bexsero) into the UK childhood immunisation schedule. SETTING: Community centres, mother and toddler groups, parents’ homes and workplaces in London and Yorkshire. PARTICIPANTS: 60 parents of children under 2 years of age recruited via mother and baby groups and via an advert posted to a midwife-led Facebook group. RESULTS: Although recognising the severity of meningitis and septicaemia, parents’ knowledge of group B meningococcal disease and MenB vaccine was poor. While nervous about fever, most said they would take their child for MenB vaccination despite its link to fever. Most parents had liquid paracetamol at home. Many were willing to administer it after MenB vaccination as a preventive measure, although some had concerns. There were mixed views on the acceptability of four vaccinations at the 12-month booster visit; some preferred one visit, while others favoured spreading the vaccines over two visits. Parents were clear on the information they required before attending the immunisation appointment. CONCLUSIONS: The successful implementation of the MenB vaccination programme depends on its acceptance by parents. In view of parents’ recognition of the severity of meningitis and septicaemia, and successful introduction of other vaccines to prevent bacterial meningitis and septicaemia, the MenB vaccination programme is likely to be successful. However, the need for additional injections, the likelihood of post-immunisation fever and its management are issues about which parents will need information and reassurance from healthcare professionals. Public Health England has developed written information for parents, informed by these findings. BMJ Open 2017-05-04 /pmc/articles/PMC5623433/ /pubmed/28473508 http://dx.doi.org/10.1136/bmjopen-2016-012851 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Immunology (Including Allergy)
Jackson, Cath
Yarwood, Joanne
Saliba, Vanessa
Bedford, Helen
UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
title UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
title_full UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
title_fullStr UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
title_full_unstemmed UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
title_short UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
title_sort uk parents’ attitudes towards meningococcal group b (menb) vaccination: a qualitative analysis
topic Immunology (Including Allergy)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623433/
https://www.ncbi.nlm.nih.gov/pubmed/28473508
http://dx.doi.org/10.1136/bmjopen-2016-012851
work_keys_str_mv AT jacksoncath ukparentsattitudestowardsmeningococcalgroupbmenbvaccinationaqualitativeanalysis
AT yarwoodjoanne ukparentsattitudestowardsmeningococcalgroupbmenbvaccinationaqualitativeanalysis
AT salibavanessa ukparentsattitudestowardsmeningococcalgroupbmenbvaccinationaqualitativeanalysis
AT bedfordhelen ukparentsattitudestowardsmeningococcalgroupbmenbvaccinationaqualitativeanalysis